DHR vs META: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Meta Platforms, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Meta Platforms, Inc. · Communication Services
$671.34
+117.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
META has more upside to fair value
(+117.9%).
META trades at a lower forward P/E
(28.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
META |
| Current Price |
$174.04 |
$671.34 |
| Fair Value Estimate |
$197.01 |
$1,463.17 |
| Upside to Fair Value |
+13.2%
|
+117.9%
|
| Market Cap |
$123.2B |
$1,698.2B |
| Forward P/E |
33.4x
|
28.0x
|
| EV / EBITDA |
20.3x
|
16.5x
|
| Price / Sales |
5.0x
|
8.4x
|
| Price / FCF |
23.3x
|
36.8x
|
| Revenue Growth YoY |
+3.7%
|
+23.8%
|
| Gross Margin |
60.7%
|
82.0%
|
| Operating Margin |
21.0%
|
41.4%
|
| Return on Equity |
7.1%
|
30.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
2.72%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Accumulation Zones
| Metric |
DHR |
META |
| Zone Low |
$147.76 |
$1,097.38 |
| Zone High |
$167.46 |
$1,243.69 |
| In Buy Zone? |
No
|
Yes
|